| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |